AC
HALO icon

Avestar Capital’s Halozyme HALO Stock Holding History

Avestar Capital’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-19,921
Closed -$1.02M – 458
2021
Q1 		$1.02M Buy
19,921
+7,517
+61% +$343K 0.23% 97
2020
Q4 		$530K Buy
12,404
+4,831
+64% +$174K 0.15% 122
2020
Q3 		$233K Buy
+7,573
New +$211K 0.08% 194

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Avestar Capital's HALO Position: Q2 2021 in Review

Avestar Capital sold out of Halozyme (HALO) in Q2 2021, closing a stake of 19,921 shares — an estimated $1.02M sold.

Avestar Capital first reported a position in HALO in Q3 2020 and held it in 3 quarters. The position peaked at $1.02M in Q1 2021. 313 funds tracked by Wall St. Rank hold HALO as of Q2 2021.

  • Avestar Capital reported no remaining Halozyme position as of Q2 2021 after selling out during the quarter.
  • Avestar Capital sold 19,921 Halozyme shares in Q2 2021, an estimated $1.02M.
  • Avestar Capital first reported a position in Halozyme in Q3 2020 and held it in 3 quarters.
  • Avestar Capital's Halozyme position peaked at $1.02M in Q1 2021.
  • 313 funds tracked by Wall St. Rank held Halozyme as of Q2 2021.

Based on Avestar Capital's 13F filing for Q2 2021, filed 3 Aug 2021.